Investment trust RTW Biotech Opportunities (LON:RTW) generated a healthy net asset value (NAV) total return of 16.5% for the six months to June 2026. That performance beat the 15.4% gain from the Nasdaq Biotech Index. However, it lagged the 28.2% rise in the Russell 2000 Biotech Smaller Companies Index. And the trust’s share price total … Continue reading RTW Biotech Opportunities delivers healthy 16.5% return